Ritonavir 100 MG Oral Powder — RxCUI 1926066
RxNorm drug concept · Semantic clinical drug
RxCUI 1926066
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1926066
Official nameRitonavir 100 MG Oral Powder
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)2,121 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Ritonavir: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Ritonavir blocks an enzyme called protease that HIV needs to replicate. Without it, the virus can't make mature copies of itself. But ritonavir on its own isn't enough to fully con...
- What exactly does ritonavir do, and why do I have to take it with other HIV medicines?
- You're right — stomach side effects like diarrhea, nausea, vomiting, and abdominal pain are very common, especially when you first start. The good news is these often improve after...
- I've heard ritonavir causes a lot of stomach problems. What should I expect?
🕸️ Concept Web — How Ritonavir 100 MG Oral Powder Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Ritonavir 100 MG Oral Powder
RxCUI 1926066 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Ritonavir
85762IN
-
Ritonavir
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Norvir
196479BN
-
Norvir
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ritonavir Oral Powder
1926065SCDF -
Ritonavir Oral Powder Product
1926064SCDG -
Ritonavir Oral Product
1165486SCDG -
Ritonavir Oral Powder [Norvir]
1926067SBDF -
Norvir Oral Powder Product
1926068SBDG -
Norvir Oral Product
1177579SBDG -
Oral Powder
346289DF -
Oral Powder Product
1294711DFG - +1 more in this family
-
Ritonavir Oral Powder
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ritonavir 100 MG
317488SCDC -
Ritonavir 100 MG Oral Powder [Norvir]
1926069SBD -
Ritonavir 100 MG [Norvir]
565134SBDC
-
Ritonavir 100 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ritonavir 100 MG
SCDC · 317488 -
Ritonavir Oral Powder
SCDF · 1926065 -
Ritonavir Oral Powder Product
SCDG · 1926064 -
Ritonavir Oral Product
SCDG · 1165486
Brand-Name Concepts
-
Ritonavir 100 MG Oral Powder [Norvir]
SBD · 1926069 -
Ritonavir 100 MG [Norvir]
SBDC · 565134 -
Ritonavir Oral Powder [Norvir]
SBDF · 1926067 -
Norvir Oral Powder Product
SBDG · 1926068 -
Norvir Oral Product
SBDG · 1177579 -
Norvir
BN · 196479
📦 FDA Products & Package NDCs
2 products · 2 package NDCs
2 package NDCs map to RxCUI 1926066 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00074-2340-30 | 30 TABLET, FILM COATED in 1 BOTTLE (0074-2340-30) | Norvir | AbbVie Inc. | 2022-08-16 |
| 00074-3399-30 | 30 PACKET in 1 CARTON (0074-3399-30) / 1 POWDER in 1 PACKET | Norvir | AbbVie Inc. | 2017-06-07 |
Observed labelers:
AbbVie Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.